Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Tissue Inhibitor of Metalloproteinase 1 Regulates Resistance to Infection
2004
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
2018 Standout
Optical coherence tomography angiography
2017 Standout
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study
2015
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation
1997
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease
2016
Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: A prospective follow-up study
2000
Ischemic optic neuropathy
2008 Standout
Intraluminal Thrombus has a Selective Influence on Matrix Metalloproteinases and Their Inhibitors (Tissue Inhibitors of Matrix Metalloproteinases) in the Wall of Abdominal Aortic Aneurysms
2012 StandoutNobel
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
The Thrombospondins
2011 Standout
MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes
1998 Standout
Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
2003
Rheumatoid Arthritis
1990
Tolerance, Danger, and the Extended Family
1994 Standout
Pathophysiology of Premature Skin Aging Induced by Ultraviolet Light
1997 Standout
Medical applications of infrared thermography: A review
2012 Standout
Giant Cell Arteritis
1994
Polymyalgia rheumatica
1997
Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy
2003
Clinical features of polymyalgia rheumatica and giant cell arteritis
2012
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
1998 Standout
Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis
2012
The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
2013
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis
2002 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant‐cell arteritis
2002
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
2007
Treatment of collagen‐induced arthritis in rats with a monoclonal antibody against the α/β T cell antigen receptor
1991
Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis
2002 StandoutNobel
Immunological Self‐Tolerance: An Analysis Employing Cytokines or Cytokine Receptors Encoded by Transgenes or a Recombinant Vaccinia Virus
1991
Steroid therapy for visual loss in patients with giant-cell arteritis
2000
Atherosclerosis — An Inflammatory Disease
1999 Standout
Role of Matrix Metalloproteinases in Human Periodontal Diseases
1993
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies
2010 Standout
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity
2000
Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001
2006
Thermography of frozen shoulder and rotator cuff tendinitis
1992
Corticosteroid Requirements in Polymyalgia Rheumatica
1999
Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment
1996
A matrix metalloproteinase expressed on the surface of invasive tumour cells
1994 StandoutNature
Visual Prognosis in Giant Cell Arteritis
1993
A Personal History of the CAMPATH-1H Antibody
2002
Giant cell arteritis with low erythrocyte sedimentation rate: Frequency of occurrence in a population-based study
2001
Effects of a novel tylophorine analog on collagen‐induced arthritis through inhibition of the innate immune response
2006 StandoutNobel
Management of Giant Cell Arteritis
2003
Mining electronic health records: towards better research applications and clinical care
2012 Standout
Ocular manifestations and concepts of systemic vasculitides
2004
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery
2022 StandoutNobel
Fish Oil, Raynaud's Syndrome, and Undiscovered Public Knowledge
1986
The structure and infrastructure of the global nanotechnology literature
2006 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Polymyositis, not polymyalgia rheumatica.
1991
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study
2016
Inflammatory and immune pathways in the pathogenesis of periodontal disease
2013 Standout
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
1996
Handbook of Quantitative Science and Technology Research
2005 Standout
PEGA supports for combinatorial peptide synthesis and solid-phase enzymatic library assays
1998 StandoutNobel
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
2007
β-Arrestin Deficiency Protects Against Pulmonary Fibrosis in Mice and Prevents Fibroblast Invasion of Extracellular Matrix
2011 StandoutNobel
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Etanercept in treatment of Felty's syndrome
2005
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
POEPOP and POEPS: Inert polyethylene glycol crosslinked polymeric supports for solid synthesis
1996 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients.
1992
Facial nerve injury during temporal artery biopsy
2014
Combined Treatment of Giant-Cell Arteritis with Methotrexate and Prednisone
2001
Incidence of Giant Cell Arteritis and Characteristics of Patients: Data‐Driven Analysis of Comorbidities
2014
Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
2016
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine
2016 StandoutNobel
Matrix Metalloproteinases: A Review
1993 Standout
Characteristics of Adverse Effects When Using High Dose Short Term Steroid Regimen
2012
Rheumatic Diseases of Childhood
1990
Design of the Tocilizumab in Giant Cell Arteritis Trial
2013
Cardiovascular toxicities associated with immune checkpoint inhibitors
2019
Works of V Kyle being referenced
Polymyalgia rheumatica/giant cell arteritis in a Cambridge general practice.
1985
Synovial fluids from infected joints contain metalloproteinase — tissue inhibitor of metalloproteinase (TIMP) complexes
1990
BSR and BHPR guidelines for the management of polymyalgia rheumatica
2009
BSR and BHPR guidelines for the management of giant cell arteritis
2010
Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritis
1991
Stopping steroids in polymyalgia rheumatica and giant cell arteritis.
1990
Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
1989
The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.
1993
Treatment of polymyalgia rheumatica/giant cell arteritis
1991
Humanized monoclonal antibody treatment in rheumatoid arthritis.
1991
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
1989
Assessment of inflammation in the rheumatoid knee joint: correlation between clinical, radioisotopic, and thermographic methods.
1986
The levels of collagenase, tissue inhibitor of metalloproteinases-1 (TIMP-1), collagenase approximately TIMP-1 complexes and glycosaminoglycan (GAG) in sequential samples of synovial fluid aspirated from patients with osteoarthritis.
1995
Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
1989
Prostaglandin E1 vasospastic disease and thermography.
1985
Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study.
1987
Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.
1989
Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.
1987